CDs for CUD in administrative data vary substantially and lack empirical validation, limiting their reliability for surveillance and comparative research. The development and validation of standardized, transparent CDs are needed to strengthen cannabis epidemiology and to support reproducible research, health-system planning, and policy decision-making.
Bahji et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: